Platelet response heterogeneity in thrombus formation
- PMID: 19967145
- DOI: 10.1160/TH09-05-0289
Platelet response heterogeneity in thrombus formation
Abstract
Vascular injury leads to formation of a structured thrombus as a consequence of platelet activation and aggregation, thrombin and fibrin formation, and trapping of leukocytes and red cells. This review summarises current evidence for heterogeneity of platelet responses and functions in the thrombus-forming process. Environmental factors contribute to response heterogeneity, as the platelets in a thrombus adhere to different substrates, and sense specific (ant)agonists and rheological conditions. Contraction of platelets and interaction with fibrin and other blood cells cause further response variation. On the other hand, response heterogeneity can also be due to intrinsic differences between platelets in age and in receptor and signalling proteins. As a result, at least three subpopulations of platelets are formed in a thrombus: aggregating platelets with (reversible) integrin activation, procoagulant (coated) platelets exposing phosphatidylserine and binding coagulation factors, and contracting platelets with cell-cell contacts. This recognition of thrombus heterogeneity has implications for the use and development of antiplatelet medication.
Similar articles
-
Platelet-vessel wall interaction in health and disease.Neth J Med. 2010 Jun;68(6):242-51. Neth J Med. 2010. PMID: 20558854 Review.
-
Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.J Clin Invest. 1994 Jan;93(1):204-11. doi: 10.1172/JCI116947. J Clin Invest. 1994. PMID: 8282789 Free PMC article.
-
Insights into platelet-based control of coagulation.Thromb Res. 2014 May;133 Suppl 2:S139-48. doi: 10.1016/S0049-3848(14)50024-2. Thromb Res. 2014. PMID: 24862135 Review.
-
Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):288-92. doi: 10.1073/pnas.0610188104. Epub 2006 Dec 26. Proc Natl Acad Sci U S A. 2007. PMID: 17190826 Free PMC article.
-
Platelet activation and its patient-specific consequences.Thromb Res. 2008;122(4):435-41. doi: 10.1016/j.thromres.2007.08.023. Epub 2007 Oct 22. Thromb Res. 2008. PMID: 17949794 Review.
Cited by
-
Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner.Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1357-62. doi: 10.1073/pnas.1209905110. Epub 2013 Jan 3. Proc Natl Acad Sci U S A. 2013. PMID: 23288905 Free PMC article.
-
Pharmacokinetic, pharmacodynamic and pharmacogenetic profile of the oral antiplatelet agent ticagrelor.Clin Pharmacokinet. 2012 May 1;51(5):305-18. doi: 10.2165/11630960-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22489610 Review.
-
Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers.PLoS One. 2013;8(3):e59368. doi: 10.1371/journal.pone.0059368. Epub 2013 Mar 15. PLoS One. 2013. PMID: 23555024 Free PMC article.
-
Single platelet variability governs population sensitivity and initiates intrinsic heterotypic responses.Commun Biol. 2020 Jun 4;3(1):281. doi: 10.1038/s42003-020-1002-5. Commun Biol. 2020. PMID: 32499608 Free PMC article.
-
Histopathological Characteristics of IV Recombinant Tissue Plasminogen -Resistant Thrombi in Patients with Acute Ischemic Stroke.J Vasc Interv Neurol. 2016 Jan;8(5):38-45. J Vasc Interv Neurol. 2016. PMID: 26958152 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials